Tumor necrosis factor-alpha levels gurrelate with a better response to adalimumab in patients with rheumatoid arthritis

被引：0
|
作者：
Cuchacovich, M.
Soto, L.
Gutierrez, M.
Llanos, C.
Sabugo, F.
Pacheco, D.
Alamos, M.
Fuentealba, C.
Villanueva, L.
Gatica, H.
Schiattino, I.
Salazar, L.
Catalan, D.
Valenzuela, O.
Salazar-Onfray, F.
Aguillon, J.
机构：
[1] Univ Chile, Hosp Clin, Dept Med, Rheumatol Sect, Santiago, Chile
[2] Catholic Univ Chile, Hosp Clin, Dept Med, Div Rheumatol, Santiago, Chile
[3] Univ Chile, San Borja Arriaran Hosp, Dept Med, Santiago, Chile
[4] Univ Chile, Fac Med, ICBM, Program Discplinary Immunol, Santiago, Chile
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [41] Effects of glucocorticoids on the levels of serum tumor necrosis factor alpha and interleukin 6 in patients with rheumatoid arthritis
    Luo, Jinwei
    Zhong, Yanqing
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (07): : 7890 - 7897
  • [42] Tumor necrosis factor alpha and TNFR2 soluble levels in rheumatoid arthritis and osteoarthritis patients
    Oregon-Romero, E.
    Mercado, M. Vazquez-Del
    Navarro-Hernandez, R. E.
    Torres-Carrillo, N.
    Torres-Carrillo, N. M.
    Munoz-Valle, J. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 136 - 136
  • [43] Serum and Urinary Levels of Tumor Necrosis Factor-Alpha in Renal Transplant Patients
    Ciftci, Hayriye Senturk
    Demir, Erol
    Karadeniz, Meltem Savran
    Tefik, Tzevat
    Yazici, Halil
    Nane, Ismet
    Oguz, Fatma Savran
    Aydin, Filiz
    Turkmen, Aydin
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2018, 16 (06) : 671 - 675
  • [44] Tear levels of tumor necrosis factor-alpha in patients with Parkinson's disease
    Comoglu, Selim Selcuk
    Guven, Hayat
    Acar, Mutlu
    Ozturk, Gulfer
    Kocer, Bilge
    NEUROSCIENCE LETTERS, 2013, 553 : 63 - 67
  • [45] A single infusion of the tumor necrosis factor-alpha antibody infliximab suppresses bone resorption in patients with rheumatoid arthritis.
    Dimai, HP
    Mueller, T
    Fahrleitner, A
    Hermann, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S274 - S275
  • [46] Tumor Necrosis Factor-Alpha Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study
    Desai, Rishi J.
    Solomon, Daniel H.
    Schneeweiss, Sebastian
    Danaei, Goodarz
    Liao, Katherine
    Kim, Seoyoung C.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [47] Risk of Serious Infection and Malignancy in Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Biologics
    Thyagarajan, Veena
    Norman, Heather
    Enger, Cheryl
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 160 - 160
  • [48] Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with etanercept, a chimeric tumor necrosis factor-alpha receptor
    Yanagida, Mitsuaki
    Jung, Giman
    Tanaka, Yoshinori
    Sone, Saburo
    Fujishiro, Maki
    Ikeda, Keigo
    Nozawa, Kazuhisa
    Kaneko, Hiroshi
    Takasaki, Yoshinari
    Ogawa, Hideoki
    Takamori, Kenji
    Sekigawa, Iwao
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2012, 15 (05) : 486 - 495
  • [49] LONG-TERM SURVIVAL OF TUMOR NECROSIS FACTOR-ALPHA INHIBITOR THERAPIES IN A SPANISH COHORT OF RHEUMATOID ARTHRITIS PATIENTS
    Caliz, R.
    Ferrer, M. A.
    Soto, M. J.
    Garcia, A.
    Utrilla, A.
    Salas, P.
    Lopez-Sidro, M.
    Romani, L.
    Acevedo, Z.
    Notario, I
    Sainz, J.
    Caliz, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 434 - 434
  • [50] SERUM LEVELS OF TUMOR NECROSIS FACTOR-ALPHA IN HAIRY-CELL LEUKEMIA - RESPONSE
    LINDEMANN, A
    OSTER, W
    MERTELSMANN, R
    HERRMANN, F
    BLOOD, 1990, 75 (01) : 322 - 323
12345